Clinical trial
EarGenie: Assessment of a Minimum Viable Product
NCT05962814 is registered in ClinicalTrials.gov with The Bionics Institute of Australia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- EarGenie: Assessment of a Minimum Viable Product
- Lead sponsor
- The Bionics Institute of Australia
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 14, 2023
- Completion date
- February 26, 2024
- Enrollment
- 11 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hearing impaired children